• Je něco špatně v tomto záznamu ?

TFG::MET-rearranged soft tissue tumor: A rare infantile neoplasm with a distinct low-grade triphasic morphology

M. Michal, N. Ud Din, M. Švajdler, N. Klubíčková, N. Ptáková, V. Hájková, M. Michal, A. Agaimy

. 2023 ; 62 (5) : 290-296. [pub] 20221213

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23003616

This article presents 2 cases of TFG::MET-rearranged mesenchymal tumor, an extremely rare molecular subset among an emerging group of mesenchymal neoplasms with kinase gene (NTRK, BRAF, RET and others) alterations. Both tumors were congenital, occurred in female patients and presented as huge masses on the trunk and thigh, measuring 18 and 20 cm in the largest dimension. Both cases showed identical areas with a distinctive triphasic morphology resembling fibrous hamartoma of infancy (FHI), consisting of haphazardly arranged ovoid to spindled cells traversed by variably cellular and hyalinized fascicles admixed with (most likely non-neoplastic) adipose tissue. In other areas, a high-grade infantile fibrosarcoma/malignant peripheral nerve sheath tumor-like (IFS/MPNST-like) morphology was present in both cases. While the first case co-expressed CD34 and S100 protein, the other case did not. When combined with the three previously reported MET-rearranged cases (of which two harbored TFG::MET fusion), 3/5 and 3/4 of MET-rearranged and TFG::MET fusion-associated tumors, respectively exhibited similar triphasic FHI-like low-grade morphology. This points toward the existence of a relatively distinct morphological subset among kinase-fusion-associated tumors which seems to be strongly associated with MET fusions. It seems some of these low-grade cases may transform into a high-grade variant with IFS/MPNST-like morphology as has been observed in other tumors with kinase gene fusions. While most cases seem to follow an indolent clinical course, the recognition of these tumors is clinically relevant as MET tyrosine kinase inhibitors might represent an effective treatment option for clinically aggressive or unresectable cases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23003616
003      
CZ-PrNML
005      
20230425140747.0
007      
ta
008      
230418s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/gcc.23111 $2 doi
035    __
$a (PubMed)36464850
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Michal, Michael $u Department of Pathology, Charles University, Faculty of Medicine in Plzen, Plzen, Czech Republic $u Bioptical Laboratory, Ltd., Plzen, Czech Republic
245    10
$a TFG::MET-rearranged soft tissue tumor: A rare infantile neoplasm with a distinct low-grade triphasic morphology / $c M. Michal, N. Ud Din, M. Švajdler, N. Klubíčková, N. Ptáková, V. Hájková, M. Michal, A. Agaimy
520    9_
$a This article presents 2 cases of TFG::MET-rearranged mesenchymal tumor, an extremely rare molecular subset among an emerging group of mesenchymal neoplasms with kinase gene (NTRK, BRAF, RET and others) alterations. Both tumors were congenital, occurred in female patients and presented as huge masses on the trunk and thigh, measuring 18 and 20 cm in the largest dimension. Both cases showed identical areas with a distinctive triphasic morphology resembling fibrous hamartoma of infancy (FHI), consisting of haphazardly arranged ovoid to spindled cells traversed by variably cellular and hyalinized fascicles admixed with (most likely non-neoplastic) adipose tissue. In other areas, a high-grade infantile fibrosarcoma/malignant peripheral nerve sheath tumor-like (IFS/MPNST-like) morphology was present in both cases. While the first case co-expressed CD34 and S100 protein, the other case did not. When combined with the three previously reported MET-rearranged cases (of which two harbored TFG::MET fusion), 3/5 and 3/4 of MET-rearranged and TFG::MET fusion-associated tumors, respectively exhibited similar triphasic FHI-like low-grade morphology. This points toward the existence of a relatively distinct morphological subset among kinase-fusion-associated tumors which seems to be strongly associated with MET fusions. It seems some of these low-grade cases may transform into a high-grade variant with IFS/MPNST-like morphology as has been observed in other tumors with kinase gene fusions. While most cases seem to follow an indolent clinical course, the recognition of these tumors is clinically relevant as MET tyrosine kinase inhibitors might represent an effective treatment option for clinically aggressive or unresectable cases.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a nádorové biomarkery $x genetika $7 D014408
650    12
$a fibrosarkom $x genetika $7 D005354
650    _2
$a fúze genů $7 D050939
650    12
$a nádory z pojivové a měkké tkáně $7 D018204
650    12
$a neurofibrosarkom $7 D018319
650    _2
$a proteiny $x genetika $7 D011506
650    12
$a nádory kůže $7 D012878
650    12
$a nádory měkkých tkání $x genetika $x patologie $7 D012983
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ud Din, Nasir $u Section of Histopathology, Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi, Pakistan
700    1_
$a Švajdler, Marián $u Department of Pathology, Charles University, Faculty of Medicine in Plzen, Plzen, Czech Republic $u Bioptical Laboratory, Ltd., Plzen, Czech Republic $1 https://orcid.org/0000000180524741 $7 xx0092880
700    1_
$a Klubíčková, Natálie $u Department of Pathology, Charles University, Faculty of Medicine in Plzen, Plzen, Czech Republic $u Bioptical Laboratory, Ltd., Plzen, Czech Republic $1 https://orcid.org/0000000244075544
700    1_
$a Ptáková, Nikola $u Bioptical Laboratory, Ltd., Plzen, Czech Republic
700    1_
$a Hájková, Veronika $u Bioptical Laboratory, Ltd., Plzen, Czech Republic
700    1_
$a Michal, Michal $u Department of Pathology, Charles University, Faculty of Medicine in Plzen, Plzen, Czech Republic $u Bioptical Laboratory, Ltd., Plzen, Czech Republic
700    1_
$a Agaimy, Abbas $u Institute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg, University Hospital, Erlangen, Germany $1 https://orcid.org/0000000204458161
773    0_
$w MED00001898 $t Genes, chromosomes & cancer $x 1098-2264 $g Roč. 62, č. 5 (2023), s. 290-296
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36464850 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425140744 $b ABA008
999    __
$a ok $b bmc $g 1924350 $s 1189825
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 62 $c 5 $d 290-296 $e 20221213 $i 1098-2264 $m Genes, chromosomes & cancer $n Genes Chromosom Cancer $x MED00001898
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace